Integrative Profiling of T790M-Negative EGFR-Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic Opportunities

• Main Authors: Chua, Khi Pin, Teng, Yvonne HF, Tan, Aaron C, Takano, Angela, Alvarez, Jacob JS, Nahar, Rahul, Rohatgi, Neha, Lai, Gillianne GY, Aung, Zaw Win, Yeong, Joe PS, Lim, Kiat Hon, Naeini, Marjan Mojtabavi, Kassam, Irfahan, Jain, Amit, Tan, Wan Ling, Gogna, Apoorva, Too, Chow Wei, Kanesvaran, Ravindran, Ng, Quan Sing, Ang, Mei Kim, Rajasekaran, Tanujaa, Anantham, Devanand, Phua, Ghee Chee, Tan, Bien Soo, Lee, Yin Yeng, Wang, Lanying, Teo, Audrey SM, Khng, Alexis Jiaying, Lim, Ming Jie, Suteja, Lisda, Toh, Chee Keong, Lim, Wan-Teck, Iyer, N Gopalakrishna, Tam, Wai Leong, Tan, Eng-Huat, Zhai, Weiwei, Hillmer, Axel M, Skanderup, Anders J, Tan, Daniel SW
• Other Authors: SURGERY
• Format: Article
• Language: English
• Published: AMER ASSOC CANCER RESEARCH 2024
• Subjects: Science & Technology; Life Sciences & Biomedicine; Oncology; CELL LUNG-CANCER; ACQUIRED-RESISTANCE; 1ST-LINE TREATMENT; OPEN-LABEL; CHECKPOINT INHIBITORS; GEFITINIB; OSIMERTINIB; EVOLUTION; AFATINIB
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/248932
• Institution: National University of Singapore

10.1158/1078-0432.CCR-20-4607